Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A
- PMID: 12754098
- DOI: 10.1016/s0006-2952(03)00155-2
Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A
Abstract
Like other G-protein coupled receptors with hydrophobic ligands, the human cannabinoid receptor 1 (CB1) is thought to bind its ligands within the transmembrane region of the receptor. However, for some of these receptors the extracellular loops (ECs) have also been shown to play a role in ligand recognition and selectivity. We have taken a mutagenesis approach to examine the role of the amino terminus, EC1, and EC3 of CB1 in ligand binding. Eight mutant receptors, each with a dipeptide insertion, were constructed, expressed, and evaluated for binding to the cannabinoid ligands (-)-cis-3[2-hydroxy-4-(1',1'-dimethylheptyl)phenyl]-trans-4-(3-hydroxypropyl)cyclohexanol (CP 55,940) and N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide hydrochloride (SR 141716A). Mutants with insertions in the membrane distal region of the amino terminus or EC3 maintained affinity for both ligands. Those with insertions in the membrane proximal region of the amino terminus or EC1 exhibited a loss of affinity for CP 55,940 while retaining wild-type affinity for SR 141716A. Representative mutants were analyzed for agonist-induced inhibition of cyclic AMP accumulation, and the results indicated that G-protein coupling remained intact. Alanine substitution mutants were made to address whether it was the perturbation of the overall structure of the region or the displacement of particular side chains that was responsible for the loss of CP 55,940 binding. We conclude that a structurally intact EC1, but not the comparably short EC3, is essential for high-affinity CP 55,940 binding.
Similar articles
-
Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.Eur J Pharmacol. 1999 Jun 25;374(3):445-55. doi: 10.1016/s0014-2999(99)00349-0. Eur J Pharmacol. 1999. PMID: 10422789
-
Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.Biochem Pharmacol. 2000 Nov 1;60(9):1315-23. doi: 10.1016/s0006-2952(00)00447-0. Biochem Pharmacol. 2000. PMID: 11008125
-
A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions.J Biol Chem. 1997 Aug 29;272(35):22330-9. doi: 10.1074/jbc.272.35.22330. J Biol Chem. 1997. PMID: 9268384
-
Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528.Life Sci. 1999;65(6-7):627-35. doi: 10.1016/s0024-3205(99)00285-4. Life Sci. 1999. PMID: 10462063 Review.
-
Molecular probes for the cannabinoid receptors.Chem Phys Lipids. 2000 Nov;108(1-2):37-52. doi: 10.1016/s0009-3084(00)00186-9. Chem Phys Lipids. 2000. PMID: 11106781 Review.
Cited by
-
Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents.Neuroimage. 2008 Jul 1;41(3):690-8. doi: 10.1016/j.neuroimage.2008.03.004. Epub 2008 Mar 18. Neuroimage. 2008. PMID: 18456516 Free PMC article.
-
The membrane proximal region of the cannabinoid receptor CB1 N-terminus can allosterically modulate ligand affinity.Biochemistry. 2013 Nov 19;52(46):8286-94. doi: 10.1021/bi400842k. Epub 2013 Nov 8. Biochemistry. 2013. PMID: 24206272 Free PMC article.
-
Discovery of Selective Cannabinoid CB2 Receptor Agonists by High-Throughput Screening.SLAS Discov. 2018 Apr;23(4):375-383. doi: 10.1177/2472555217748403. Epub 2017 Dec 19. SLAS Discov. 2018. PMID: 29257918 Free PMC article.
-
Understanding functional residues of the cannabinoid CB1.Curr Top Med Chem. 2010;10(8):779-98. doi: 10.2174/156802610791164210. Curr Top Med Chem. 2010. PMID: 20370713 Free PMC article. Review.
-
Prejunctional and peripheral effects of the cannabinoid CB(1) receptor inverse agonist rimonabant (SR 141716).Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):345-69. doi: 10.1007/s00210-008-0327-2. Epub 2008 Jul 25. Naunyn Schmiedebergs Arch Pharmacol. 2008. PMID: 18654765 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous